Chinook Therapeutics Announces Pricing of a $105 Million Public Offering
SEATTLE, May 24, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY) today announced the pricing of its underwritten public…
Pharmaceuticals, Biotechnology and Life Sciences
SEATTLE, May 24, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY) today announced the pricing of its underwritten public…
Verrica has been advised that PAI (Pre-Approval Inspection) was conducted at Sterling and is not aware of any reported observations…
Form 20-F Filed on May 23, 2022 Following Receipt of Notice from Nasdaq Regarding Filing Deadline of its Annual ReportNEW…
TORONTO and CHICAGO, May 24, 2022 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) has been informed by medac, a…
–NGM707, NGM Bio’s most advanced myeloid reprogramming antibody product candidate, will be showcased in the third of a four-part series…
– The Pure-Vu system improved the adequate cleansing rate more than 200% to 97.7% in patients with a history of…
ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 24, 2022 Cambridge,…
SEATTLE, May 24, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development…
TORONTO, May 24, 2022 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), a premier provider of unified eClinical solutions and services…
Leuven, BELGIUM, Boston, MA, US – MAY 24, 2022 – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next…